More News
15 January 2013
Versartis Closes $25 Million Series C Financing15 January 2013
Change to the Roche Corporate Executive Committee15 January 2013
AstraZeneca announces changes to Senior Executive Team14 January 2013
AstraZeneca and Vanderbilt University Collaborate to Develop Novel Treatments for Major Brain Disorders14 January 2013
Horizon Discovery and Boehringer Ingelheim Enter Oncology Research Service Collaboration14 January 2013
PharmAthene Secures Exclusive License To PER.C6® Cell Line For Commercial Production Of Recombinant Bioscavenger14 January 2013
Aileron Therapeutics Secures $12 Million for First-Ever Stapled Peptide Clinical Trial9 January 2013
Adimab Expands Collaborations with Merck and Lilly9 January 2013
NewVac Signs License and Co-Development Agreement With Janssen to Advance Novel Drug for Treatment of Solid Tumors9 January 2013
OPKO Health to acquire privately held Cytochroma8 January 2013
Daiichi Sankyo and Amplimmune Announce Strategic Alliance to Develop AMP-110 Therapy for Autoimmune Disease8 January 2013
Shire Acquires Lotus Tissue Repair, Inc.8 January 2013
BioMarin Acquires Zacharon Pharmaceuticals8 January 2013
EISAI SIGNS AGREEMENT WITH EPIZYME AND ROCHE MOLECULAR SYSTEMS TO DEVELOP COMPANION DIAGNOSTIC8 January 2013
Chugai and Debiopharm Group Announce an Exclusive License Agreement for Anti-Cancer Agent, FF284 (Debio 1347)News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe![Newsletter La Merie Biologics](https://pipelinereview.com/wp-content/uploads/2024/02/newsletter-1.png)
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe![Newsletter new product alert](https://pipelinereview.com/wp-content/uploads/2024/02/report-alert.png)
Featured reports